Anna Meurer, MPHProgram Manager for Education, Center for Bioethics

Anna Meurer is the Program Manager for Education for the Center for Bioethics at The Ohio State University. In her role, she oversees the administrative aspects the Center’s educational offerings as well as general Center operations. Anna holds a BA in History and Religion from Georgetown College and an MPH with an emphasis in Community Health Education from Eastern Kentucky University. She is currently pursuing a PhD in Healthcare Ethics at Duquesne University.

Research and Education Interests

Her dissertation research focuses on the exercise of professional discretion within health care, and she has additional interests in bioethics education, public health ethics, and the intersection of ethics and the built environment. She also has an interest in improving education-related administrative infrastructure and the student experience, including Learning Analytics and accessibility.

Education and Training

MA PhD Candidate in Healthcare Ethics, Duquesne University
MPH, Eastern Kentucky University
BA History and Religion, Georgetown College

Areas of Interest

Public health ethics, virtue ethics, bioethics education.

Professional Certifications

  • Certified in Public Health (CPH), National Board of Public Health Examiners (2018 - present)


  • Graduate and Professional Advisory Council (2022-present)
  • Bioethics Network of Ohio (BENO) Board Member (2021-present)
  • Non-Scientific Reviewer, University of Pittsburgh IRB (2021-present)

Recent Publications

  • Meurer A. “The End of the ‘Bad Seed’ Era? Epigenetics’ Contribution to Violence Prevention Initiatives in Public Health.” The New Bioethics 27, no. 2 (2021): 159-175.
  • Meurer A. “Uneasy Alliance: Pediatric Decision Making When Maltreatment is Suspected or Known.” Pediatric Ethicscope Spring-Fall 2022;34(1-2).
  • Flaherty A and Meurer A. “Unbefriended, Uninvited: How End-of-Life Doulas Can Address Ethical and Procedural Gaps for Unrepresented Patients and Ensure Equal Access to the ‘Good Death.’” Clinical Ethics 18, no. 1 (2023): 55-61.